Cell-based therapeutics from an economic perspective: primed for a commercial success or a research sinkhole?
暂无分享,去创建一个
Marcin Maruszewski | N. L'Heureux | T. McAllister | N. Dusserre | M. Maruszewski | Nathalie Dusserre | Todd N McAllister | Nicolas L'heureux | N. L’Heureux
[1] A. Gonshor,et al. Histologic evaluation of a stem cell-based sinus-augmentation procedure. , 2009, Journal of periodontology.
[2] L. BenMohamed,et al. Antitumor activity of a self-adjuvanting glyco-lipopeptide vaccine bearing B cell, CD4+ and CD8+ T cell epitopes , 2009, Cancer Immunology, Immunotherapy.
[3] J. Leor,et al. Myocardial repair: from salvage to tissue reconstruction , 2008, Expert review of cardiovascular therapy.
[4] Ana Jaklenec,et al. Great expectations: private sector activity in tissue engineering, regenerative medicine, and stem cell therapeutics. , 2008, Tissue engineering. Part A.
[5] D. Duncker,et al. Cell transplantation for cardiac regeneration: where do we stand? , 2008, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.
[6] Sergio Garrido,et al. Technology Insight: the evolution of tissue-engineered vascular grafts—from research to clinical practice , 2007, Nature Clinical Practice Cardiovascular Medicine.
[7] N. L'Heureux,et al. Human tissue-engineered blood vessels for adult arterial revascularization , 2007, Nature Medicine.
[8] James J. Yoo,et al. Tissue-engineered autologous bladders for patients needing cystoplasty , 2006, The Lancet.
[9] P. Kemp. Cell therapy – back on the up-curve , 2006 .
[10] C. Scott,et al. Chasing a cellular fountain of youth , 2005, Nature Biotechnology.
[11] Dawn Pedrotty,et al. Blood vessels engineered from human cells , 2005, The Lancet.
[12] K. Schulman,et al. Clinical Outcomes and Costs Due to Staphylococcus aureus Bacteremia Among Patients Receiving Long-Term Hemodialysis , 2005, Infection Control & Hospital Epidemiology.
[13] K. Anstrom,et al. Costs and Outcomes Among Hemodialysis-Dependent Patients With Methicillin-Resistant or Methicillin-Susceptible Staphylococcus aureus Bacteremia , 2005, Infection Control & Hospital Epidemiology.
[14] G. Pellegrini. Changing the cell source in cell therapy? , 2004, The New England journal of medicine.
[15] T. Okano,et al. Corneal reconstruction with tissue-engineered cell sheets composed of autologous oral mucosal epithelium. , 2004, The New England journal of medicine.
[16] Michael J Lysaght,et al. Tissue engineering: the end of the beginning. , 2004, Tissue engineering.
[17] S. Wilson,et al. Superiority of Autogenous Arteriovenous Hemodialysis Access: Maintenance of Function with Fewer Secondary Interventions , 2004, Annals of vascular surgery.
[18] Elseviers Mm,et al. Identifying vascular access complications among ESRD patients in Europe. A prospective, multicenter study. , 2003 .
[19] Aaron Bouchie,et al. Tissue engineering firms go under , 2002, Nature Biotechnology.
[20] R. Poveda,et al. Goodpasture syndrome during the course of a Schönlein-Henoch purpura. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[21] S. Berman. Vascular Access for Hemodialysis , 2002 .
[22] M J Lysaght,et al. The growth of tissue engineering. , 2001, Tissue engineering.
[23] Y. Imai,et al. Transplantation of a tissue-engineered pulmonary artery. , 2001, The New England journal of medicine.
[24] V. Falanga,et al. An economic assessment of Apligraf® (Graftskin) for the treatment of hard‐to‐heal venous leg ulcers , 2000, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[25] A. Hagège,et al. Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. , 2000, The Journal of thoracic and cardiovascular surgery.
[26] S. Wilson,et al. A Prospective Evaluation of PTFE Graft Patency and Surveillance Techniques in Hemodialysis Access , 1999, Annals of vascular surgery.
[27] F A Auger,et al. A completely biological tissue‐engineered human blood vessel , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[28] T. Howard,et al. Comparison of survival of an expanded polytetrafluoroethylene graft designed for early cannulation to standard wall polytetrafluoroethylene grafts. , 1996, Journal of the American College of Surgeons.
[29] A. Demetriou,et al. Matrix-Induced Liver Cell Aggregates (MILCA) for Bioartificial Liver Use , 1996, The International journal of artificial organs.
[30] J. Vacanti,et al. Formation of urothelial structures in vivo from dissociated cells attached to biodegradable polymer scaffolds in vitro. , 1992, The Journal of urology.
[31] H. Smits. The clinical context of technology assessment. , 1984, Journal of health politics, policy and law.
[32] E Bell,et al. The reconstitution of living skin. , 1983, The Journal of investigative dermatology.
[33] Jasper Becker,et al. Joint Research Centre , 1982, Nature.
[34] I. Yannas,et al. Wound tissue can utilize a polymeric template to synthesize a functional extension of skin. , 1982, Science.